Author,Year,Title,Journal title,URL,DOI,IN/EX,Date published,Type,WHY,Disease,Notes,who,Brasil Ministério da Saúde,Rajendran,Yue,Valk,Seth,Peru National Institute of Health,Ville,Abdelmoneim,Dwi Putera,Sun,Devasenapathy,Piechotta,Bakhtawar,Sarkar,Wooding,Davies,Aviani,Mathew,Galvan,Chen,Khadka,Platero-Portillo,Liu,Chai,Piscoya,Xuanguo,Rojas,Senefeld,Keikha,Ahmad,Meher,Wang,Wenjing,Weijun,Zafanello,Zuniga,Wardhani,Vegivinti,Sarfarz,Klassen,Aviani,Janiaud,"Advisory Committee on Biotechnologies, Ministry of Health",Prasad,Barreira,Zeng,Bansal,Kanj,Tortosa,Piechotta
J. Holst,1919,Convalescent serum in the treatment of influenza,Norsk magasin for lægevidenskaben,http://www.epistemonikos.org/documents/425c1a07063bdd23a46f5d02f23b5fef9b7588d7,,IN,02/04/1905,non rct,,,,BW,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"S. Lie-yong, Z. Pei-fen and F. Fang",2011,Retrospective study on collecting convalescent donors′s plasma in treatment of patients with pandemic influenza A(H1N1) virus infection,Chinese Hounal of Nosocomiology,http://www.epistemonikos.org/documents/b1a7c68bfbca11345025619a666d14a200d861f0,,in,03/07/1905,non rct,,H1N1,,JTC,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
L. W. McGuire and W. R. Redden,1918,Treatment of Influenza Pneumonia by the Use of Convalescent Human Serum: Preliminary Report,Journal of the American Medical Association,http://www.epistemonikos.org/documents/1fb775f6af3aa59ba8e8f1ce74de848c60b96c34,10.1001/jama.1918.26020420013013e,in,19/10/1918,case report study,,influenza,,JTC,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
C. W. Ross and E. J. Hund,1918,Transfusion in the Desperate Pneumonias Complicating Influenza,Journal of the American Medical Association,http://www.epistemonikos.org/documents/bed8e28d075f5aeea8b4298e8476f8602f537aa5,10.1001/jama.1918.26020500018006e,IN,14/12/1918,case series reports,,Influenza,,MR,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
L. Ehrenberg and A. Barkman,1919,Convalescent serum in the prevention and treatment of influenza,Hygiea,http://www.epistemonikos.org/documents/bdc683b3fb760d0b23f80d2fd955f28a0bfd92c2,,IN,01/01/1919,case report study,,FLU,,BA,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
M. H. Kahn,1919,Serum Treatment of Postinfluenzal Bronchopneumonia,Journal of the American Medical Association,http://www.epistemonikos.org/documents/ddbd966db141c310c6cbf9e4a5e90812381e723b,10.1001/jama.1919.02610020020007,IN,11/01/1919,non rct,,,,BW,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,
C. W. Ross and E. J. Hund,1919,Treatment of the Pneumonic Disturbance Complicating Influenza,Journal of the American Medical Association,http://www.epistemonikos.org/documents/5d511a2a13e06967bfbdeca7fc764d1c4c339aac,10.1001/jama.1919.02610090024007,IN,01/03/1919,case series reports,,Influenza,,MR,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
L. W. McGuire and W. R. Redden,1919,Treatment of Influenzal Pneumonia by the Use of Convalescent Human Serum: Second Report,Journal of the American Medical Association,http://www.epistemonikos.org/documents/67ae0afb2cf8329ab484640c39e300cb771730f5,10.1001/jama.1919.02610100017007,in,08/03/1919,case report study,,influenza,,JTC,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
H. F. Stoll,1919,Value of convalescent blood and serum in treatment of influenzal pneumonia,Journal of the American Medical Association,http://www.epistemonikos.org/documents/aedcd7a6005e19d93a38e4507509e2b93701ce58,,IN,16/08/1919,non rct,,Inluenzal pneumonia (1918),,NO,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
W. R. Redden,1919,Treatment of influenza-pneumonia by use of convalescent human serum,The Boston Medical and Surgical Journal,http://www.epistemonikos.org/documents/b19dc38c9f4126d9922740059563a2f8ebeb97cf,,IN,11/12/1919,case series reports,,Influenza,,MR,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
G. P. Sanborn,1920,The use of the serum of convalescents in the treatment of influenza pneumonia: A summary of the results in a series of one hundred and one cases,The Boston Medical and Surgical Journal,http://www.epistemonikos.org/documents/9e66ec0dced07573474ccb30c9cb08d1deed8a3f,,IN,08/05/1920,case series reports,,,,NO,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,
"K. Mupapa, M. Massamba, K. Kibadi, K. Kuvula, A. Bwaka, M. Kipasa, R. Colebunders and J. J. Muyembe-Tamfum",1999,Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee,J Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/9988160,10.1086/514298,IN,01/02/1999,case series reports,,Ebola,,MR,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"X. Z. Zhou, M. Zhao, F. S. Wang, T. J. Jiang, Y. G. Li, W. M. Nie, Z. P. Zhou, Y. Wang, J. He, R. Fan, J. M. Zhao and X. W. Zhang",2003,"[Epidemiologic features, clinical diagnosis and therapy of first cluster of patients with severe acute respiratory syndrome in Beijing area]",Zhonghua Yi Xue Za Zhi,https://www.ncbi.nlm.nih.gov/pubmed/12899773,10.3760/j:issn:0376-2491.2003.12.00510bcb169da11101823,IN,06/01/2003,case report study,,SARS,,NO,,,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"V. W. Wong, D. Dai, A. K. Wu and J. J. Sung",2003,Treatment of severe acute respiratory syndrome with convalescent plasma,Hong Kong Med J,https://www.ncbi.nlm.nih.gov/pubmed/12777656,,IN,01/06/2003,case report study,,SARS,,NO,,,,,,,,,,1,,,,,1,,1,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,
L. Kong,2003,Severe acute respiratory syndrome (SARS),Transfusion and Apheresis Science,http://www.epistemonikos.org/documents/310b5cd2a35d93dfa9908034e70428e10d564435,10.1016/s1473-0502(03)00109-5,IN,01/08/2003,case report study,,SARS,,JTC,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,
"Y. O. Soo, Y. Cheng, R. Wong, D. S. Hui, C. K. Lee, K. K. Tsang, M. H. Ng, P. Chan, G. Cheng and J. J. Sung",2004,Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients,Clin Microbiol Infect,https://www.ncbi.nlm.nih.gov/pubmed/15214887,10.1111/j.1469-0691.2004.00956.x,IN,18/06/2004,non rct,,SARS,,NO,,,,,,,,,,1,1,,,,1,,1,,1,,,,,,,,,,1,,,,,,,,,,,,1,,,,,1,,,,
"Y. Cheng, R. Wong, Y. O. Soo, W. S. Wong, C. K. Lee, M. H. Ng, P. Chan, K. C. Wong, C. B. Leung and G. Cheng",2005,Use of convalescent plasma therapy in SARS patients in Hong Kong,Eur J Clin Microbiol Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/15616839,10.1007/s10096-004-1271-9,IN,23/12/2004,non rct,,SARS,,BA,,,1,,,,,,,1,,,,,1,,1,,1,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,
"K. M. Yeh, T. S. Chiueh, L. K. Siu, J. C. Lin, P. K. Chan, M. Y. Peng, H. L. Wan, J. H. Chen, B. S. Hu, C. L. Perng, J. J. Lu and F. Y. Chang",2005,Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital,J Antimicrob Chemother,https://www.ncbi.nlm.nih.gov/pubmed/16183666,10.1093/jac/dki346,IN,23/09/2005,case report study,,SARS,,BA,,1,1,,,,,,,1,,,,,1,,1,,1,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,
L. K. Kong and B. P. Zhou,2006,Successful treatment of avian influenza with convalescent plasma,Hong Kong Med J,https://www.ncbi.nlm.nih.gov/pubmed/17148811,,IN,01/12/2006,case report study,,avian influenza,,JTC,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Zhou, B. P., Zhong, N. S. and Guan, Y.",2007,Treatment with convalescent plasma for influenza A (H5N1) infection,N Engl J Med,https://www.ncbi.nlm.nih.gov/pubmed/17914053,10.1056/NEJMc070359,IN,04/10/2007,case report study,,Influenza,,MR,,,,,,,,,,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,
"I. F. Hung, K. K. To, C. K. Lee, K. L. Lee, K. Chan, W. W. Yan, R. Liu, C. L. Watt, W. M. Chan, K. Y. Lai, C. K. Koo, T. Buckley, F. L. Chow, K. K. Wong, H. S. Chan, C. K. Ching, B. S. Tang, C. C. Lau, I. W. Li, S. H. Liu, K. H. Chan, C. K. Lin and K. Y. Yuen",2011,Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection,Clin Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/21248066,10.1093/cid/ciq106,IN,19/01/2011,non rct,,,,BW,,,,,,,,,,1,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,1,,,,
"I. F. N. Hung, K. K. W. To, C. K. Lee, K. L. Lee, W. W. Yan, K. Chan, W. M. Chan, C. W. Ngai, K. I. Law, F. L. Chow, R. Liu, K. Y. Lai, C. C. Y. Lau, S. H. Liu, K. H. Chan, C. K. Lin and K. Y. Yuen",2013,Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection,Chest,https://www.ncbi.nlm.nih.gov/pubmed/23450336,10.1378/chest.12-2907,IN,01/08/2013,rct,,,,BW,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,
"C. S. Kraft, A. L. Hewlett, S. Koepsell, A. M. etal",2015,The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States,Clin Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/25904375,10.1093/cid/civ334,IN,22/04/2015,case report study,,ebola,,JTC,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"D. F. Florescu, A. C. Kalil, A. L. Hewlett, A. J. Schuh, U. Stroher, T. M. Uyeki and P. W. Smith",2015,Administration of Brincidofovir and Convalescent Plasma in a Patient With Ebola Virus Disease,Clin Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/25991468,10.1093/cid/civ395,IN,19/05/2015,case report study,,Ebola,,BA,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"M. Mora-Rillo, M. Arsuaga, G. Ramírez-Olivencia, F. de la Calle, A. M. Borobia, P. etal",2015,"Acute respiratory distress syndrome after convalescent plasma use: treatment of a patient with Ebola virus disease contracted in Madrid, Spain",The Lancet Respiratory Medicine,http://www.epistemonikos.org/documents/ed7b402e752d4566b80ae557a510be9cfcffdc72,10.1016/s2213-2600(15)00180-0,IN,31/05/2015,case report study,,Ebola,,MR,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"X. X. Wu, H. N. Gao, H. B. Wu, X. M. Peng, H. L. Ou and L. J. Li",2015,Successful treatment of avian-origin influenza A (H7N9) infection using convalescent plasma,Int J Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/26482389,10.1016/j.ijid.2015.10.009,IN,01/12/2015,case report study,,avian origin influenza,,AB,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"J. van Griensven, T. Edwards, X. de Lamballerie, M. G. Semple, etal",2016,Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea,N Engl J Med,https://www.ncbi.nlm.nih.gov/pubmed/26735992,10.1056/NEJMoa1511812,IN,07/01/2016,non rct,,Ebola,,NO,,,,,,,,,,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,
"W. S. Choi, C. I. Kang, Y. Kim, J. P. Choi, J. S. Joh, H. S. Shin, G. Kim, K. R. Peck, D. R. Chung, H. O. Kim, S. H. Song, Y. R. Kim, K. M. Sohn, Y. Jung, J. H. Bang, N. J. Kim, K. S. Lee, H. W. Jeong, J. Y. Rhee, E. S. Kim, H. Woo, W. S. Oh, K. Huh, Y. H. Lee, J. Y. Song, J. Lee, C. S. Lee, B. N. Kim, Y. H. Choi, S. J. Jeong, J. S. Lee, J. H. Yoon, Y. M. Wi, M. K. Joung, S. Y. Park, S. H. Lee, S. I. Jung, S. W. Kim, J. H. Lee, H. Lee, H. K. Ki, Y. S. Kim and D. Korean Society of Infectious",2016,Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of Korea,Infect Chemother,https://www.ncbi.nlm.nih.gov/pubmed/27433382,10.3947/ic.2016.48.2.118,IN,30/06/2016,non rct,,MERS,,BA,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,
"S. Chun, C. R. Chung, Y. E. Ha, T. H. Han, C. S. Ki, E. S. Kang, J. K. Park, K. R. Peck and D. Cho",2016,Possible Transfusion-Related Acute Lung Injury Following Convalescent Plasma Transfusion in a Patient With Middle East Respiratory Syndrome,Ann Lab Med,https://www.ncbi.nlm.nih.gov/pubmed/27139619,10.3343/alm.2016.36.4.393,IN,01/07/2016,case report study,,MERS,,BA,,,1,,,,,,,,,,,,1,,1,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,
"Y. M. Arabi, A. H. Hajeer, T. Luke, K. Raviprakash, H. Balkhy, S. Johani, A. Al-Dawood, S. Al-Qahtani, A. Al-Omari, F. Al-Hameed, F. G. Hayden, R. Fowler, A. Bouchama, N. Shindo, K. Al-Khairy, G. Carson, Y. Taha, M. Sadat and M. Alahmadi",2016,"Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia",Emerg Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/27532807,10.3201/eid2209.151164,IN,22/09/2016,non rct,,MERS-CoV,feasibility study,AB,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"F. Sahr, R. Ansumana, T. A. Massaquoi, B. R. Idriss, F. R. Sesay, J. M. Lamin, S. Baker, S. Nicol, B. Conton, W. Johnson, O. T. Abiri, O. Kargbo, P. Kamara, A. Goba, J. B. Russell and S. M. Gevao",2017,"Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone",J Infect,https://www.ncbi.nlm.nih.gov/pubmed/27867062,10.1016/j.jinf.2016.11.009,IN,17/11/2016,non rct,,Ebola,,NO,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,
"J. H. Beigel, P. Tebas, M. C. Elie-Turenne, E. Bajwa, T. E. Bell, C. B. Cairns, S. Shoham, J. G. Deville, E. Feucht, J. Feinberg, T. Luke, K. Raviprakash, J. Danko, D. O'Neil, J. A. Metcalf, K. King, T. H. Burgess, E. Aga, H. C. Lane, M. D. Hughes, R. T. Davey and I. R. C. S. Team",2017,"Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study",Lancet Respir Med,https://www.ncbi.nlm.nih.gov/pubmed/28522352,10.1016/S2213-2600(17)30174-1,IN,15/05/2017,non rct,,influenza,"Again, not sure if immune plasma the same as convalescent plasma",AB,,,,,,,,,,1,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,1,,,,
"J. H. Ko, H. Seok, S. Y. Cho, Y. E. Ha, J. Y. Baek, S. H. Kim, Y. J. Kim, J. K. Park, C. R. Chung, E. S. Kang, D. Cho, M. A. Muller, C. Drosten, C. I. Kang, D. R. Chung, J. H. Song and K. R. Peck",2018,Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience,Antivir Ther,https://www.ncbi.nlm.nih.gov/pubmed/29923831,10.3851/IMP3243,IN,20/06/2018,case report study,,MERS,,JTC,,,1,,,,,,,,,,,,1,,1,,1,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,
J. J. O'Malley and F. W. Hartman,1919,Treatment of influenzal pneumonia with plasma of convalescent patients,Journal of the American Medical Association,http://www.epistemonikos.org/documents/de4e39a3c47b4a81b99c76b81ef8f00b194fc9e8,,IN,04/01/2019,case series reports,,Pneumonia,,MR,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,
"R. T. Davey, Jr., E. Fernandez-Cruz, N. Markowitz, S. Pett, A. G. Babiker, D. Wentworth, S. Khurana, N. Engen, F. Gordin, M. K. Jain, V. Kan, M. N. Polizzotto, P. Riska, K. Ruxrungtham, Z. Temesgen, J. Lundgren, J. H. Beigel, H. C. Lane, J. D. Neaton and I. F.-I. S. Group",2019,"Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial",Lancet Respir Med,https://www.ncbi.nlm.nih.gov/pubmed/31582358,10.1016/S2213-2600(19)30253-X,IN,30/09/2019,rct,,FLU,,BA,,,,,,,,,,,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,1,,,,
"J. H. Beigel, E. Aga, M. C. Elie-Turenne, J. Cho, P. Tebas, C. L. Clark, J. P. Metcalf, C. Ozment, K. Raviprakash, J. Beeler, H. P. Holley, Jr., S. Warner, C. Chorley, H. C. Lane, M. D. Hughes, R. T. Davey, Jr. and I. R. C. S. Team",2019,"Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial",Lancet Respir Med,https://www.ncbi.nlm.nih.gov/pubmed/31582360,10.1016/S2213-2600(19)30199-7,IN,30/09/2019,rct,,influenza,Wasn't sure if immune plasma was the same as convalescent plasma,AB,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,
"D. Balashov, P. Trakhtman, A. Livshits, I. Kovalenko, G. Tereshenko, G. Solopova, E. Petraikina, A. Maschan and G. Novichkova",2021,SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation,Transfusion and Apheresis Science,<Go to ISI>://WOS:000639152200043,10.1016/j.transci.2020.102983,IN,11/01/2020,case report study,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,1,,,,,,,,,,
"A. Karatas, A. C. Inkaya, H. Demiroglu, S. Aksu, T. Haziyev, O. E. Cinar, A. Alp, O. Uzun, N. Sayinalp and H. Goker",2020,Prolonged viral shedding in a lymphoma patient with COVID-19 infection receiving convalescent plasma,Transfus Apher Sci,https://www.ncbi.nlm.nih.gov/pubmed/32694044,10.1016/j.transci.2020.102871,IN,07/03/2020,case report study,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,1,,,,,,,,1,,,,,,,,,,
"S. Luo, L. Yang, C. Wang, C. Liu and D. Li",2020,[Clinical observation of 6 severe COVID-19 patients treated with plasma exchange or tocilizumab],Zhejiang Da Xue Xue Bao Yi Xue Ban,,10.3785/j.issn.1008-9292.2020.03.06,in,13/03/2020,case report study,,,,JTC,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"H. Shi, C. Zhou, P. He, S. Huang, Y. Duan, X. Wang, K. Lin, C. Zhou, X. Zhang and Y. Zha",2020,Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19,Int J Antimicrob Agents,,10.1016/j.ijantimicag.2020.105974,IN,13/03/2020,case report study,,,,NO,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"K. Duan, B. Liu, C. Li, H. Zhang, T. Yu, J. Qu, M. Zhou, L. Chen, etal",2020,The feasibility of convalescent plasma therapy in severe COVID-19 patients: a pilot study,medRxiv,http://www.epistemonikos.org/documents/aab3b35b3b7b77ef118c6861f1f8e5e85fd02c98,10.1101/2020.03.16.20036145,IN,23/03/2020,non rct,,,,NO,,,,1,1,,,,,1,,1,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,
"C. Shen, Z. Wang, F. Zhao, Y. Yang, J. Li, J. Yuan, F. Wang, D. Li, M. Yang, L. Xing, J. Wei, H. Xiao, Y. Yang, J. Qu, L. Qing, L. Chen, Z. Xu, L. Peng, Y. Li, H. Zheng, F. Chen, K. Huang, Y. Jiang, D. Liu, Z. Zhang, Y. Liu and L. Liu",2020,Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma,JAMA,https://www.ncbi.nlm.nih.gov/pubmed/32219428,10.1001/jama.2020.4783,IN,27/03/2020,case series reports,,,,NO,1,1,,1,1,,1,1,1,1,,1,1,,1,,1,1,1,1,1,1,,,1,1,,,1,,1,1,,,,,,,,1,1,,,,,,1,1,,
"B. Zhang, S. Liu, T. Tan, W. Huang, Y. Dong, L. Chen, Q. Chen, L. Zhang, Q. Zhong, X. Zhang, Y. Zou and S. Zhang",2020,Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection,Chest,https://www.ncbi.nlm.nih.gov/pubmed/32243945,10.1016/j.chest.2020.03.039,IN,31/03/2020,case series reports,,,,NO,1,1,,1,1,,1,1,1,1,,1,1,,1,,,1,,1,1,1,,,1,1,,,1,,,1,,,,,,,,1,,,,,,,1,1,,
"S. Pei, X. Yuan, Z. Zhang, R. Yao, Y. Xie, M. Shen, B. Li, X. Chen and M. Yin",2020,Convalescent Plasma to Treat COVID-19: Chinese Strategy and Experiences,medRxiv,http://www.epistemonikos.org/documents/cd6cbf33d0c4565b50e87748f7d24abf6dba28c2,10.1101/2020.04.07.20056440,IN,11/04/2020,case report study,,,,MR,,,,1,1,,1,,,,,1,1,,,,1,,,,1,,,,1,,,,,,,,,,,,,,,,1,,,,,,1,,,
"J. Y. Ahn, Y. Sohn, S. H. Lee, Y. Cho, J. H. Hyun, Y. J. Baek, S. J. Jeong, J. H. Kim, N. S. Ku, J. S. Yeom, J. Roh, M. Y. Ahn, B. S. Chin, Y. S. Kim, H. Lee, D. Yong, H. O. Kim, S. Kim and J. Y. Choi",2020,Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea,J Korean Med Sci,https://www.ncbi.nlm.nih.gov/pubmed/32281317,10.3346/jkms.2020.35.e149,IN,13/04/2020,case series reports,,,2 cases,AB,,1,,1,1,,1,1,1,1,,1,1,,1,,1,,,,1,1,,,1,1,,,1,,,1,,,,,,,,1,1,,,,,,1,1,,
"L. Zhang, R. Pang, X. Xue, J. Bao, S. Ye, Y. Dai, Y. Zheng, Q. Fu, Z. Hu and Y. Yi",2020,Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19,Aging (Albany NY),https://www.ncbi.nlm.nih.gov/pubmed/32320384,10.18632/aging.103102,IN,22/04/2020,case report study,,,,NO,,,,1,,,1,,,,,1,1,,,,,,,,,1,,,,1,,,,,,,,,,,,,,1,,,,,,,,,,
"K. Duan, B. Liu, C. Li, H. Zhang, T. Yu, J. Qu,etal",2020,Effectiveness of convalescent plasma therapy in severe COVID-19 patients,Proc Natl Acad Sci U S A,https://www.ncbi.nlm.nih.gov/pubmed/32253318,10.1073/pnas.2004168117,IN,28/04/2020,non rct,,,,NO,1,1,,1,,,1,1,1,,,1,1,1,1,1,1,1,1,1,1,1,,1,1,1,,,1,,1,1,,,,,,1,,1,1,,,,1,,1,1,,
"Q. L. Zeng, Z. J. Yu, J. J. Gou, G. M. Li, S. H. Ma, G. F. Zhang, J. H. Xu, W. B. Lin, G. L. Cui, M. M. Zhang, C. Li, Z. S. Wang, Z. H. Zhang and Z. S. Liu",2020,Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in Patients With Coronavirus Disease 2019,J Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/32348485,10.1093/infdis/jiaa228,IN,29/04/2020,non rct,,,,NO,,,,,1,,,,,,,1,1,1,1,1,1,1,1,,1,1,1,1,1,1,,,1,1,1,1,1,,,,1,1,,1,1,,,,1,,1,1,,
"Yang X, Sui Y, Liu F, Kang Z, Wu S and Z. J",2020,Clinical characteristics and convalescent plasma therapy in severe and critically ill COVID-19 patients,preprint with The Lancet,,DOI: 10.2139/ssrn.3576894,in,05/05/2020,non rct,,,,JTC,,,,,,,,,,,,1,,,,,1,,,,1,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,
"E. Salazar, K. K. Perez, M. Ashraf, J. Chen, B. Castillo, P. A. Christensen, etal",2020,"Treatment of COVID-19 Patients with Convalescent Plasma in Houston, Texas",medRxiv,https://www.ncbi.nlm.nih.gov/pubmed/32511574,10.1101/2020.05.08.20095471,IN,13/05/2020,non rct,,,,NO,,,,,1,,,,,,,1,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"M. J. Joyner, R. S. Wright, D.etal",2020,Early safety indicators of COVID-19 convalescent plasma in 5000 patients,Medrxiv,,,IN,14/05/2020,non rct,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,
"J. Anderson, J. Schauer, S. Bryant and C. R. Graves",2020,The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report,Case Rep Womens Health,https://www.ncbi.nlm.nih.gov/pubmed/32426243,10.1016/j.crwh.2020.e00221,IN,16/05/2020,case report study,,,,BW,,,,,,,,,,,,1,,,,,,,,,1,,,,,1,,,,,,1,,,,,,,,1,,,,,,,,1,,
"Y. Kong, C. Cai, L. Ling, L. Zeng, M. Wu, Y. Wu, W. Zhang and Z. Liu",2020,Successful treatment of a centenarian with coronavirus disease 2019 (COVID-19) using convalescent plasma,Transfus Apher Sci,https://www.ncbi.nlm.nih.gov/pubmed/32467007,10.1016/j.transci.2020.102820,IN,21/05/2020,case report study,,,,BW,,,,,,,1,,,,,1,,,,,,1,,,,,,,,1,,,,,,1,,,,,,,,1,,,,,,,,1,,
"S. T. H. Liu, H. M. Lin, I. Baine, A. Wajnberg, J. P. Gumprecht, F. etal",2020,Convalescent plasma treatment of severe COVID-19: a matched control study,medRxiv ,,,IN,22/05/2020,non rct,,,,BW,,,,,1,1,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
"Y. Bao, S. Y. Lin, Z. H. Cheng, J. Xia, Y. P. Sun, Q. Zhao and G. J. Liu",2020,Clinical Features of COVID-19 in a Young Man with Massive Cerebral Hemorrhage-Case Report,SN comprehensive clinical medicine,,10.1007/s42399-020-00315-y,IN,23/05/2020,case report study,,,,JTC,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,1,,
"K. Xiao, Y. Lin, Z. Fan, Y. Wen, H. Huang, M. Wang, D. Ren, C. Wu, W. Liu, Z. Zhang, G. Li and A. Le",2020,Effect of transfusion convalescent recovery plasma in patients with coronavirus disease 2019,Zhong Nan Da Xue Xue Bao Yi Xue Ban,https://www.ncbi.nlm.nih.gov/pubmed/32879108,10.11817/j.issn.1672-7347.2020.200318,IN,28/05/2020,non rct,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,
"O. E. Cinar, B. Sayinalp, E. Aladag Karakulak, A. Avsar Karatas, M. Velet, A. C. Inkaya, N. E. Ersoy Ortac, S. Ocal, S. Aksu, I. C. Haznedaroglu, N. Sayinalp and O. I. Ozcebe",2020,Convalescent (immune) plasma treatment in a myelodysplastic COVID-19 patient with disseminated tuberculosis,Transfus Apher Sci,https://www.ncbi.nlm.nih.gov/pubmed/32487513,10.1016/j.transci.2020.102821,IN,29/05/2020,case report study,,,,MR,,,,,,,,,,,,1,,,,,,,,,,,,,,1,,1,,,,1,,,,,,,,1,,,,,,,,1,,
"C. Perotti, F. Baldanti, R. Bruno, C. Del Fante, E. Seminari, S. Casari, E. Percivalle, C. Glingani, V. Musella, M. Belliato, M. Garuti, F. Meloni, M. Frigato, A. Di Sabatino, C. Klersy, G. De Donno, M. Franchini and C.-P. T. Collaborative",2020,"Mortality reduction in 46 patients with severe COVID-19 treated with hyperimmune plasma A proof-of-concept, single-arm, multicenter trial",medRxiv,,https://www.medrxiv.org/content/10.1101/2020.05.26.20113373v1,IN,29/05/2020,non rct,,,,AB,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,,1,,,,,,,,,,,,,,,,
"J. C. Olivares-Gazca, J. M. Priesca-Marin, M. Ojeda-Laguna, J. Garces-Eisele, S. etal",2020,Infusion of Convalescent Plasma Is Associated with Clinical Improvement in Critically Ill Patients with Covid-19: A Pilot Study,Rev Invest Clin,https://www.ncbi.nlm.nih.gov/pubmed/32584322,10.24875/RIC.20000237,IN,01/06/2020,non rct,,,,MR,,,,,,,,,,,,,,,,,,,1,,,1,,1,1,,,,,,,1,,,,,,,,1,,,,,,,1,1,,
"L. Li, W. Zhang, Y. Hu, X. Tong, S. Zheng, J. Yang, Y. Kong, L. Ren, Q. Wei, H. Mei, C. Hu, C. Tao, R. Yang, J. Wang, Y. Yu, Y. Guo, X. Wu, Z. Xu, L. Zeng, N. Xiong, L. Chen, J. Wang, N. Man, Y. Liu, H. Xu, E. Deng, X. Zhang, C. Li, C. Wang, S. Su, L. Zhang, J. Wang, Y. Wu and Z. Liu",2020,Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial,JAMA,https://www.ncbi.nlm.nih.gov/pubmed/32492084,10.1001/jama.2020.10044,IN,03/06/2020,rct,,,,BW,,,,,,1,1,,,,,1,1,1,1,1,1,,1,,,,1,1,1,1,1,,1,1,1,1,1,1,,1,1,1,1,1,1,1,,1,1,,1,1,1,1
"H. Zeng, D. Wang, J. Nie, H. Liang, J. Gu, A. Zhao, L. Xu, C. Lang, X. Cui, X. Guo, C. Zhou, H. Li, B. Guo, J. Zhang, Q. Wang, L. Fang, W. Liu, Y. Huang, W. Mao, Y. Chen and Q. Zou",2020,The efficacy assessment of convalescent plasma therapy for COVID-19 patients: a multi-center case series,Signal Transduct Target Ther,https://www.ncbi.nlm.nih.gov/pubmed/33024082,10.1038/s41392-020-00329-x,IN,10/06/2020,case series reports,,,,NO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,1,1,,,,,,,,,,
"M. J. Joyner, R. S. Wright, D.etal",2020,Early safety indicators of COVID-19 convalescent plasma in 5000 patients,J Clin Invest,https://www.ncbi.nlm.nih.gov/pubmed/32525844,10.1172/JCI140200,IN,11/06/2020,non rct,,,,BW,,,,,1,,1,,,,,1,,1,1,,,,1,,1,,,,,1,,,1,,1,,,,,,,,,1,,,,,,,,,,1
"S. Hatzl, F. Eisner, G. Schilcher, P. Kreuzer, M. Gornicec, P. Eller, M. Brodmann, P. Schlenke, M. H. Stradner, R. Krause, H. Greinix and E. Schulz",2020,"Response to ""COVID-19 in persons with haematological cancers""",Leukemia,https://www.ncbi.nlm.nih.gov/pubmed/32528043,10.1038/s41375-020-0914-x,IN,11/06/2020,non rct,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,,
"A. Niu, A. McDougal, B. Ning, F. Safa, A. Luk, D. M. Mushatt, A. Nachabe, K. J. Zwezdaryk, J. Robinson, T. Peterson, F. Socola, H. Safah, T. Hu and N. S. Saba",2020,COVID-19 in allogeneic stem cell transplant: high false-negative probability and role of CRISPR and convalescent plasma,Bone Marrow Transplant,https://www.ncbi.nlm.nih.gov/pubmed/32541689,10.1038/s41409-020-0972-8,IN,15/06/2020,case series reports,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,,
"Madariaga, Maria Lucia Schrantz, Stephen Jansen, Maud O. etal",2020,Integrated COVID-19 Convalescent Plasma Treatment and Antibody Research Program at a Single Academic Medical Center,SSRN,,,IN,16/06/2020,non rct,,,added in late,AB,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,
"T. M. Xu, B. Lin, C. Chen, L. G. Liu and Y. Xue",2020,Non-optimal effectiveness of convalescent plasma transfusion and hydroxychloroquine in treating COVID-19: a case report,Virol J,https://www.ncbi.nlm.nih.gov/pubmed/32560646,10.1186/s12985-020-01354-6,in,19/06/2020,case report study,,,,JTC,,,,,,,,,,,,,,,,,,,,,,1,,,,1,,,,,,1,,,,,,,,1,,,,,,,,1,,
"W. Hartman, A. S. Hess and J. P. Connor",2020,Hospitalized COVID-19 patients treated with Convalescent Plasma in a mid-size city in the midwest,medRxiv,https://www.ncbi.nlm.nih.gov/pubmed/32607514,10.1101/2020.06.19.20135830,IN,22/06/2020,non rct,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,1,1,,,,,,,,,,,,,,,1,,,,,,,,,,1
"Madariaga, Maria Lucia L. Guthmiller, Jenna J. Schrantz, Stephen etal",2020,Clinical predictors of donor antibody titer and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial,Medrxiv,,,IN,23/06/2020,non rct,,,added in late,AB,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,
"H. M. Abdullah, H. H. Hama-Ali, S. N. Ahmed, K. M. Ali, K. A. Karadakhy, S. O. Mahmood, Z. H. Mahmood, K. Q. Hamad Amin, P. M. Atta, B. E. Nuradeen, S. H. Mohammed, R. Q. Salih, H. O. Baba and F. H. Kakamad",2020,A severe refractory COVID-19 patient responding to convalescent plasma,Ann Med Surg (Lond),https://www.ncbi.nlm.nih.gov/pubmed/32637086,10.1016/j.amsu.2020.06.018,IN,24/06/2020,case report study,,,two cases,AB,,,,,,,,,,,,,,,,1,,,,,,,,,1,1,,,,,,,1,,,,,,,,,,,,,,,,,
"Z. Wright, A. Bersabe, R. Eden, J. Bradley and A. Cap",2021,Successful Use of COVID-19 Convalescent Plasma in a Patient Recently Treated for Follicular Lymphoma,Clin Lymphoma Myeloma Leuk,https://www.ncbi.nlm.nih.gov/pubmed/32682684,10.1016/j.clml.2020.06.012,IN,25/06/2020,case report study,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,,
"C. Jin, J. Gu, Y. Yuan, Q. Long, Q. Zhang, H. Zhou, W. Wu and W. Zhang",2020,Treatment of Six COVID-19 Patients with Convalescent Plasma,medRxiv,https://www.medrxiv.org/content/medrxiv/early/2020/06/25/2020.05.21.20109512.full.pdf,10.1101/2020.05.21.20109512,IN,25/06/2020,non rct,,,,BW,,,,,1,,,,,,,1,,,,,,,,,,,,1,1,,,,,,1,,,,,,,,,1,,,,,,,,1,,
"M. Hahn, M. E. H. Condori, A. Totland, E. K. Kristoffersen and T. A. Hervig",2020,[A patient with severe COVID-19 treated with convalescent plasma],Tidsskr Nor Laegeforen,,10.4045/tidsskr.20.0501,IN,26/06/2020,case report study,,,,AB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"J. H. Im, C. H. Nahm, J. H. Baek, H. Y. Kwon and J. S. Lee",2020,Convalescent Plasma Therapy in Coronavirus Disease 2019: a Case Report and Suggestions to Overcome Obstacles,J Korean Med Sci,https://www.ncbi.nlm.nih.gov/pubmed/32627442,10.3346/jkms.2020.35.e239,IN,26/06/2020,case report study,,,,BA,,,,,,,,,,,,,,,1,,,,,,,1,,,,,,,,,,1,,,,,,,,1,,,,,,,,1,,
"M. A. Erkurt, A. Sarici, I. Berber, I. Kuku, E. Kaya and M. Ozgul",2020,Life-saving effect of convalescent plasma treatment in covid-19 disease: Clinical trial from eastern Anatolia,Transfus Apher Sci,https://www.ncbi.nlm.nih.gov/pubmed/32620409,10.1016/j.transci.2020.102867,IN,27/06/2020,non rct,,,Not sure if I have the type of evidence correct here,AB,,,,,,,,,,,,,,,1,,,,1,,,,,,1,,,,,,1,,,,,,,,,1,,,,,,,1,,,
"M. Ye, D. Fu, Y. Ren, F. Wang, D. Wang, F. Zhang, X. Xia and T. Lv",2020,"Treatment with convalescent plasma for COVID-19 patients in Wuhan, China",J Med Virol,https://www.ncbi.nlm.nih.gov/pubmed/32293713,10.1002/jmv.25882,IN,29/06/2020,case series reports,,,,MR,,1,,1,1,,1,,1,,,1,1,,1,,1,,1,,1,,,,1,1,,1,1,,,1,,,,,,,,1,1,,,,,,1,1,,
"A. M. Rasheed, D. F. Fatak, H. A. Hashim, M. F. Maulood, K. K. Kabah, Y. A. Almusawi and A. S. Abdulamir",2020,"The therapeutic effectiveness of Convalescent plasma therapy on treating COVID-19 patients residing in respiratory care units in hospitals in Baghdad, Iraq",medRxiv,http://www.epistemonikos.org/documents/de40b30f31e6d1e7bfce61191ff4cf8e4e5e0a7c,10.1101/2020.06.24.20121905,IN,30/06/2020,non rct,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,1,1,,,,,,,,,1,,,,,,1,,,,1,,,,,,
"I. Bobek, L. Gopcsa, M. Réti, G. Bekő, L. Hancz, B. Lakatos, E. Molnár, S. Nagy, P. Reményi, G. Sebestyén, J. Sinkó, J. Szlávik, M. Szolnoky and I. Vályi-Nagy",2020,[Successful administration of convalescent plasma in critically ill COVID-19 patients in Hungary: the first two cases],Orv Hetil,,10.1556/650.2020.31901,IN,01/07/2020,case report study,,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,1,,,,,,,,1,,
"F. Jamous, N. Meyer, D. Buus, H. Ateeli, K. Taggart, T. Hanson, M. Alzoubaidi, J. Nazir and J. Devasahayam",2020,Critical Illness Due to Covid-19: A Description of the Surge in a Single Center in Sioux Falls,South Dakota medicine : the journal of the South Dakota State Medical Association,,,IN,01/07/2020,non rct,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,1,,
"M. Figlerowicz, A. Mania, K. Lubarski, Z. Lewandowska, W. Sluzewski, K. Derwich, J. Wachowiak and K. Mazur-Melewska",2020,First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia,Transfus Apher Sci,https://www.ncbi.nlm.nih.gov/pubmed/32636116,10.1016/j.transci.2020.102866,IN,01/07/2020,case report study,,,1 case,AB,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,1,,,1,,,,,1,,,,,,,,,,
"S. Bhumbra, S. Malin, L. Kirkpatrick, A. Khaitan, C. C. John, C. M. Rowan and L. A. Enane",2020,Clinical Features of Critical Coronavirus Disease 2019 in Children,Pediatr Crit Care Med,,10.1097/pcc.0000000000002511,IN,02/07/2020,non rct,,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"A. Gharbharan, C. C. E. Jordans, C. GeurtsvanKessel, J. G. den Hollander, F. Karim and F. P. N. Mollema",2020,Convalescent plasma for COVID-19. A randomized clinical trial,medRxiv,,,IN,03/07/2020,rct,,,,AB,,,,,,,,,,,,,,1,1,,,,,,,,,1,1,,1,,,1,1,1,1,1,,,1,1,1,1,,1,,1,1,,1,1,1,1
"E. Mira, O. A. Yarce, C. Ortega, S. Fernandez, N. M. Pascual, C. Gomez, M. A. Alvarez, I. J. Molina, R. Lama and M. Santamaria",2020,Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma,J Allergy Clin Immunol Pract,https://www.ncbi.nlm.nih.gov/pubmed/32652231,10.1016/j.jaip.2020.06.046,in,08/07/2020,case report study,,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,,
"H. Abolghasemi, P. Eshghi, A. M. Cheraghali, A. A. I. Fooladi, F. B. Moghaddam, S. Imanizadeh, M. M. Maleki, M. Ranjkesh, M. Rezapour, A. Bahramifar, B. Einollahi, M. J. Hosseini, N. J. Jafari, M. Nikpouraghdam, N. Sadri, M. Tazik, S. Sali, S. Okati, E. Askari, P. Tabarsi, J. Aslani, E. Sharifipour, M. H. Jarahzadeh, N. Khodakarim, M. Salesi, R. Jafari and S. Shahverdi",2020,Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study,Transfusion and Apheresis Science,<Go to ISI>://WOS:000594183900016,10.1016/j.transci.2020.102875,IN,15/07/2020,non rct,,,,AB,,,,,,,,,,,,,,,,,,,1,,,,1,1,1,,,,,1,,1,1,1,,1,1,1,1,1,,,1,1,1,,1,1,,
"J. Jiang, Y. Miao, Y. Zhao, X. Lu, P. Zhou, X. Zhou, Z. Chen and D. Du",2020,Convalescent plasma therapy: Helpful treatment of COVID-19 in a kidney transplant recipient presenting with severe clinical manifestations and complex complications,Clin Transplant,https://www.ncbi.nlm.nih.gov/pubmed/32602952,10.1111/ctr.14025,IN,15/07/2020,case report study,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,1,,,,,,,,1,,,,,,,,,,
"H. Peng, T. Gong, X. Huang, X. Sun, H. Luo, W. Wang, J. Luo, B. Luo, Y. Chen, X. Wang, H. Long, H. Mei, C. Li, Y. Dai and H. Li",2020,A synergistic role of convalescent plasma and mesenchymal stem cells in the treatment of severely ill COVID-19 patients: a clinical case report,Stem Cell Res Ther,https://www.ncbi.nlm.nih.gov/pubmed/32678017,10.1186/s13287-020-01802-8,IN,16/07/2020,case report study,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,1,,,,,,,,1,,
"E. Clark, P. Guilpain, I. L. Filip, N. Pansu, C. Le Bihan, G. Cartron, E. Tchernonog, C. Roubille, D. Morquin, A. Makinson, E. Tuaillon and V. Le Moing",2020,Convalescent plasma for persisting COVID-19 following therapeutic lymphocyte depletion: a report of rapid recovery,Br J Haematol,https://www.ncbi.nlm.nih.gov/pubmed/32593180,10.1111/bjh.16981,IN,16/07/2020,case report study,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,,
"M. J. Joyner, K. A. Bruno, S. A. Klassen, K. L. Kunze, P. W. Johnson, E. R. Lesser, C. C. Wiggins, J. W. Senefeld, A. M. Klompas, D. O. Hodge, J. R. A. Shepherd, R. F. Rea, E. R. Whelan, A. J. Clayburn, M. R. Spiegel, S. E. Baker, K. F. Larson, J. G. Ripoll, K. J. Andersen, M. R. Buras, M. N. P. Vogt, V. Herasevich, J. J. Dennis, R. J. Regimbal, P. R. Bauer, J. E. Blair, C. M. van Buskirk, J. L. Winters, J. R. Stubbs, N. van Helmond, B. P. Butterfield, M. A. Sexton, J. C. Diaz Soto, N. S. Paneth, N. C. Verdun, P. Marks, A. Casadevall, D. Fairweather, R. E. Carter and R. S. Wright",2020,"Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients",Mayo Clin Proc,https://www.ncbi.nlm.nih.gov/pubmed/32861333,10.1016/j.mayocp.2020.06.028,IN,19/07/2020,non rct,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,1,,,,,,,,1,,,,,,,1,,,1
"M. F. Martinez-Resendez, F. Castilleja-Leal, A. Torres-Quintanilla, A. Rojas-Martinez, G. etal",2020,"Initial experience in Mexico with convalescent plasma in COVID-19 patients with severe respiratory failure, a retrospective case series",medRxiv,http://www.epistemonikos.org/documents/8db7fb2b203cd42d25f2403b0cc4b17b59905b09,10.1101/2020.07.14.20144469,in,20/07/2020,case report study,,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,1,,,,,,,1,1,,
"B. Wei, X. Hang, Y. Xie, Y. Zhang, J. Wang, X. Cao, J. J. Wu and J. Wang",2020,Long-term positive severe acute respiratory syndrome coronavirus 2 ribonucleic acid and therapeutic effect of antivirals in patients with coronavirus disease: Case reports,Rev Soc Bras Med Trop,,10.1590/0037-8682-0372-2020,IN,20/07/2020,case report study,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"R. Jafari, N. Jonaidi-Jafari, F. Dehghanpoor and A. Saburi",2020,Convalescent plasma therapy in a pregnant COVID-19 patient with a dramatic clinical and imaging response: A case report,World J Radiol,https://www.ncbi.nlm.nih.gov/pubmed/32850016,10.4329/wjr.v12.i7.137,IN,28/07/2020,case report study,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,1,,,,,,,,,,,,,,,,,,
"M. C. Easterlin, T. De Beritto, A. M. Yeh, F. B. Wertheimer and R. Ramanathan",2020,Extremely Preterm Infant Born to a Mother With Severe COVID-19 Pneumonia,J Investig Med High Impact Case Rep,,10.1177/2324709620946621,IN,29/07/2020,case report study,,,,NO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"E. Salazar, K. K. Perez, M. Ashraf, J. Chen, B. Castillo, etal",2020,Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma,Am J Pathol,https://www.ncbi.nlm.nih.gov/pubmed/32473109,10.1016/j.ajpath.2020.05.014,IN,01/08/2020,non rct,,,,NO,,,,,,,1,,,,,,,,,,,1,,,,,,,,1,,,,1,,1,,,,,,,,,,,,1,,,,,,
"M. L. Donato, S. Park, M. Baker, R. Korngold, A. Morawski, X. Geng, etal",2020,Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma: a prospective study,medRxiv,http://www.epistemonikos.org/documents/5caeafb1a5a9a61702184256f8a0dc3492c359fb,10.1101/2020.07.20.20156398,IN,04/08/2020,non rct,2 & 3 same study,,,NO,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,1,,1,1,,,,,,,1,,,,,,,,1,,
"S. Chen, C. Lu, P. Li, L. Wang, H. Wang, Q. Yang, L. Chen, J. Li, H. Ma, Q. Sang, J. Li, L. Xu, X. Song, F. Li, Y. Zhang, Y. Kang, L. Xing and G. Zhang",2020,Effectiveness of Convalescent Plasma for Treatment of COVID-19 Patients,medRxiv,https://www.medrxiv.org/content/medrxiv/early/2020/08/04/2020.08.02.20166710.full.pdf,10.1101/2020.08.02.20166710,IN,04/08/2020,case report study,,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,
Z. Liu,2020,Errors in Trial of Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19,JAMA,https://www.ncbi.nlm.nih.gov/pubmed/32749486,10.1001/jama.2020.12607,in,04/08/2020,rct,erratum,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,1
"X. Xia, K. Li, L. Wu, Z. Wang, etal",2020,Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion,Blood,https://www.ncbi.nlm.nih.gov/pubmed/32573724,10.1182/blood.2020007079,IN,06/08/2020,non rct,,,,BW,,,,,1,,,,,,,,,,,,,,,,,,,1,,,,,,1,,1,1,,,,1,,1,1,,,,1,1,,1,1,,
"L. Hegerova, T. A. Gooley, K. A. Sweerus, C. Maree, N. Bailey, M. Bailey, V. Dunleavy, K. Patel, K. Alcorn, R. Haley, J. M. Johnsen, B. A. Konkle, A. C. Lahti, M. L. Alexander, J. D. Goldman, A. Lipke, S. J. Lim, M. D. Sullivan, J. S. Pauk and J. M. Pagel",2020,Use of convalescent plasma in hospitalized patients with COVID-19: case series,Blood,https://www.ncbi.nlm.nih.gov/pubmed/32559767,10.1182/blood.2020006964,IN,06/08/2020,case series reports,,,,BA,,,,,1,,,,,,,,,,1,1,,,,,,,1,1,1,1,,,,1,,1,,1,,,1,1,,1,,,,1,1,,1,1,,1
"E. Salazar, P. A. Christensen, E. A. Graviss, D. T. Nguyen, B. Castillo, J. Chen, B. V. Lopez, T. N. Eagar, X. Yi, P. Zhao, J. Rogers, A. Shehabeldin, D. Joseph, C. Leveque, R. J. Olsen, D. W. Bernard, J. Gollihar and J. M. Musser",2020,Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality,Am J Pathol,https://www.ncbi.nlm.nih.gov/pubmed/32795424,10.1016/j.ajpath.2020.08.001,IN,10/08/2020,non rct,,,,NO,,,,,,,,,,,,1,,,,,,,,,,,,1,1,,,,,,,,,,,,1,,,1,,,,,,,1,,,
"M. J. Joyner, J. W. Senefeld, etal",2020,Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience,medRxiv,https://www.ncbi.nlm.nih.gov/pubmed/32817978,10.1101/2020.08.12.20169359,IN,12/08/2020,non rct,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,1,1,,,,,1,,1,,,,,,,,,,,,,,,,1,,1
E. Aksoy and T. Oztutgan,2020,COVID-19 Presentation in Association with Myasthenia Gravis: A Case Report and Review of the Literature,Case Rep Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/32850160,10.1155/2020/8845844,IN,18/08/2020,case report study,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,
"S. Naeem, R. Gohh, G. Bayliss, C. Cosgrove, D. Farmakiotis, B. Merhi, P. Morrissey, A. Osband, J. A. Bailey, J. Sweeney and R. Rogers",2021,Successful recovery from COVID-19 in three kidney transplant recipients who received convalescent plasma therapy,Transpl Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/32815238,10.1111/tid.13451,in,19/08/2020,case report study,,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,1,,,,,,,,1,,,,,,,,,,
"R. Rogers, F. Shehadeh, E. K. Mylona, J. Rich, M. Neill, F. Touzard-Romo, S. Geffert, J. Larkin, J. A. Bailey, S. Lu, J. Sweeney and E. Mylonakis",2020,Convalescent plasma for patients with severe COVID-19: a matched cohort study,medRxiv,,,IN,21/08/2020,non rct,,,,NO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,
"L. Dulipsingh, D. Ibrahim, E. J. Schaefer, R. Crowell, M. R. Diffenderfer, K. Williams, C. Lima, J. McKenzie, L. Cook, J. Puff, M. Onoroski, D. B. Wakefield, R. J. Eadie, S. B. Kleiboeker, P. Nabors and S. A. Hussain",2020,SARS-CoV-2 serology and virology trends in donors and recipients of convalescent plasma,Transfus Apher Sci,,10.1016/j.transci.2020.102922,IN,25/08/2020,non rct,,,,NO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"Dulipsingh, Latha Ibrahim, Danyal Schaefer, Ernst J etal",2020,SARS-CoV-2 Serology and Virology Trends in Donors and Recipients of Convalescent Plasma,SSRN,,,IN,25/08/2020,non rct,,,added in late,AB,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,,,,,
"C. Avendaño-Solà, A. Ramos-Martínez, E. Muñez-Rubio, B. Ruiz-Antorán, etal",2020,"Convalescent Plasma for COVID-19: A multicenter, randomized clinical trial",medRxiv,http://www.epistemonikos.org/documents/7b77772e0f23865c5417d5b22476d1c157f0f184,10.1101/2020.08.26.20182444,IN,01/09/2020,rct,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,,1,,1,,,,,1,,1,,,,,,1,,1,,1,1,,1,1,1,1
"S. H. Ebrahim, M. C. Abdulla, A. S. P. Prabhu, E. M. Afsal, S. B. Pullichola and N. Karekadavath",2020,"Convalescent Plasma Therapy in First Four Critically Ill COVID-19 Patients in Kerala, India",Dr. Sulaiman Al Habib Medical Journal,http://www.epistemonikos.org/documents/c83747245fbbcf0f0045db20cccb3dc1718e50cb,10.2991/dsahmj.k.200908.001,IN,01/09/2020,case report study,,,,NO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,
"A. M. Rasheed, D. F. Fatak, H. A. Hashim, M. F. Maulood, K. K. Kabah, Y. A. Almusawi and A. S. Abdulamir",2020,"The therapeutic potential of convalescent plasma therapy on treating critically-ill COVID-19 patients residing in respiratory care units in hospitals in Baghdad, Iraq",Infez Med,https://www.ncbi.nlm.nih.gov/pubmed/32920571,,IN,01/09/2020,non rct,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,1,1,,,,1,1,,,,,,,,,1,1,,
"J. Christensen, D. Kumar, I. Moinuddin, A. Bryson, Z. Kashi, P. Kimball, M. Levy, L. Kamal, A. King and G. Gupta",2020,"Coronavirus Disease 2019 Viremia, Serologies, and Clinical Course in a Case Series of Transplant Recipients",Transplant Proc,https://www.ncbi.nlm.nih.gov/pubmed/33012543,10.1016/j.transproceed.2020.08.042,IN,03/09/2020,case series reports,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,,
"C. Diorio, E. M. Anderson, K. O. McNerney, E. C. Goodwin, J. C. etal",2020,Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome,Pediatr Blood Cancer,https://www.ncbi.nlm.nih.gov/pubmed/32885904,10.1002/pbc.28693,IN,04/09/2020,case series reports,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,1,,,1,,,,,1,,,,,,,,,,
"M. Wang, X. Yang, F. Yang, X. Zhu, Z. Sun, P. Bao and Y. Yan",2020,"Convalescent plasma therapy in critically ill coronavirus disease 2019 patients with persistently positive nucleic acid test, case series report",Medicine (Baltimore),https://www.ncbi.nlm.nih.gov/pubmed/32898996,10.1097/MD.0000000000021596,IN,04/09/2020,case series reports,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,1,,,,,,,1,,,
"A. A. Al Helali, G. A. Saeed, T. I. Elholiby, M. A. Kukkady and S. S. A. Mazrouei",2020,Radiological and clinical improvement in a patient with COVID-19 pneumonia postconvalescent plasma transfusion: A case report,Radiol Case Rep,https://www.ncbi.nlm.nih.gov/pubmed/32901209,10.1016/j.radcr.2020.07.031,IN,04/09/2020,case report study,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,
"R. Valentini, J. Fernández, D. Riveros, F. Pálizas, J. Solimano, P. Saúl, J. Medina, V. Falasco, M. L. Dupont, J. Laviano, F. Fornillo, D. Maymó, D. Gotta, A. Martinez, P. Bonvehí and J. Dupont",2020,Convalescent plasma as potential therapy for severe COVID-19 pneumonia,medRxiv,http://www.epistemonikos.org/documents/36875de92684efb7ba2d566067e601976789ab68,10.1101/2020.09.01.20184390,IN,07/09/2020,non rct,,,,AB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,
"V. Pappa, M. Politou, S. G. Papageorgiou, A. Antoniadou, A. Kotanidou, etal",2020,A Prospective Phase II Study on The Use Of Convalescent Plasma Monotherapy For The Treatment of Severe Covid-19 Disease: A Preliminary Report,ResearchSquare,http://www.epistemonikos.org/documents/5ddc37b0c97939d7a930c72efcf77f501356bba9,10.21203/rs.3.rs-64465/v1,IN,08/09/2020,case series reports,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,
"Y. Maor, D. Cohen, N. Paran, T. Israely, V. Ezra, O. Axelrod, E. etal",2020,Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma,EClinicalMedicine,https://www.ncbi.nlm.nih.gov/pubmed/32923991,10.1016/j.eclinm.2020.100525,in,09/09/2020,non rct,,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,1,,,,,,,1,,,
"A. Agarwal, A. Mukherjee, G. Kumar, P. Chatterjee, T. Bhatnagar and P. Malhotra",2020,Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial),medRxiv,http://www.epistemonikos.org/documents/7df86b07e853c0d02dcaf8ab67a3d73198fc2e03,10.1101/2020.09.03.20187252,IN,10/09/2020,rct,,,phase II,AB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,1
"S. T. H. Liu, H. M. Lin, I. Baine, A. Wajnberg, J. P. Gumprecht, F. etal",2020,Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study,Nat Med,https://www.ncbi.nlm.nih.gov/pubmed/32934372,10.1038/s41591-020-1088-9,IN,15/09/2020,non rct,,,,BW,,,,,,,1,,,,,,,1,1,,,,,,,,,,1,,,,,1,1,1,1,1,,,,1,1,1,,,,1,1,,1,1,,
"H. Jin, J. C. Reed, S. T. H. Liu, H. E. Ho, J. P. Lopes, N. B. Ramsey, O. Waqar, F. Rahman, J. A. Aberg, N. M. Bouvier, C. Cunningham-Rundles and T. Mount Sinai Health System Convalescent Plasma",2020,Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma,J Allergy Clin Immunol Pract,https://www.ncbi.nlm.nih.gov/pubmed/32947026,10.1016/j.jaip.2020.08.059,IN,15/09/2020,case report study,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,1,,,,,1,,,,,,,,1,,
"D. Tremblay, C. Seah, T. Schneider, S. Bhalla, J. Feld, L. Naymagon, B. Wang, V. Patel, T. Jun, T. Jandl, F. Rahman, S. T. H. Liu, J. A. Aberg, N. Bouvier and T. Mount Sinai Health System Convalescent Plasma",2020,Convalescent Plasma for the Treatment of Severe COVID-19 Infection in Cancer Patients,Cancer Med,https://www.ncbi.nlm.nih.gov/pubmed/32945149,10.1002/cam4.3457,IN,17/09/2020,non rct,,,,AB,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,1,,
"W. R. Hartman, A. S. Hess and J. P. Connor",2020,Hospitalized COVID-19 Patients treated with Convalescent Plasma in a Mid-size City in the Midwest,ResearchSquare,http://www.epistemonikos.org/documents/59af9b2b7cf8b03a07f272b39e231505e9291ba7,10.21203/rs.3.rs-54167/v2,IN,17/09/2020,non rct,Same as above (which was a pre-print),,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,
"M. E. Balcells, L. Rojas, N. Le Corre, C. Martínez-Valdebenito, M. E. Ceballos, M. Ferrés, M. Chang, C. Vizcaya, S. Mondaca, Á. Huete, R. Castro, M. Sarmiento, L. Villarroel, A. Pizarro, P. Ross, J. Santander, B. Lara, M. Ferrada, S. Vargas-Salas, C. Beltrán-Pavez, R. Soto-Rifo, F. Valiente-Echeverría, C. Caglevic, M. Mahave, C. Selman, R. Gazitúa, J. L. Briones, F. Villarroel-Espindola, C. Balmaceda, M. A. Espinoza, J. Pereira and B. Nervi",2020,Early Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Trial,medRxiv,http://www.epistemonikos.org/documents/263cf746fc07d732d30703802a50e3cc8851adbd,10.1101/2020.09.17.20196212,IN,18/09/2020,rct,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,1,,,,,,,
"F. Altuntas, N. Ata, T. N. Yigenoglu, S. Basci, M. S. Dal, S. Korkmaz, S. Namdaroglu, A. Basturk, T. Hacibekiroglu, M. H. Dogu, I. Berber, K. Dal, K. Kinik, I. Haznedaroglu, F. M. Yilmaz, I. Kilic, S. Demircioglu, A. Yosunkaya, M. A. Erkurt, B. Turgut, M. Caglayan and O. Celik",2021,Convalescent plasma therapy in patients with COVID-19,Transfus Apher Sci,https://www.ncbi.nlm.nih.gov/pubmed/33011076,10.1016/j.transci.2020.102955,IN,19/09/2020,non rct,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,1,1,,1,,,,1,,,1,1,,
"T. Hueso, C. Pouderoux, H. Pere, A. L. Beaumont, L. A. Raillon, F. Ader, L. Chatenoud, D. Eshagh, T. A. Szwebel, M. Martinot, F. Camou, E. Crickx, M. Michel, M. Mahevas, D. Boutboul, E. Azoulay, A. Joseph, O. Hermine, C. Rouzaud, S. Faguer, P. Petua, F. Pommeret, S. Clerc, B. Planquette, F. Merabet, J. London, V. Zeller, D. Ghez, D. Veyer, A. Ouedrani, P. Gallian, J. Pacanowski, A. Mekinian, M. Garnier, F. Pirenne, P. Tiberghien and K. Lacombe",2020,Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19,Blood,https://www.ncbi.nlm.nih.gov/pubmed/32959052,10.1182/blood.2020008423,IN,21/09/2020,case series reports,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,1,,
"Z. Rodriguez, A. L. Shane, H. Verkerke, C. Lough, M. G. Zimmerman, M. Suthar, J. Wrammert, H. MacDonald, M. Wolf, S. Clarke, J. D. Roback, C. M. Arthur, S. R. Stowell and C. D. Josephson",2020,COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease,Blood Adv,https://www.ncbi.nlm.nih.gov/pubmed/32915971,10.1182/bloodadvances.2020002507,IN,22/09/2020,case report study,,,,NO,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,1,,,,,1,,,,,,,,,,
"J. H. Baang, C. Smith, C. Mirabelli, A. L. Valesano, D. M. Manthei, M. Bachman, C. E. Wobus, M. Adams, L. Washer, E. T. Martin and A. S. Lauring",2020,Prolonged SARS-CoV-2 replication in an immunocompromised patient,medRxiv,http://www.epistemonikos.org/documents/186e2efc3b99dea321e68230fcd53712ccbd485e,10.1101/2020.09.20.20196899,IN,22/09/2020,case report study,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,,
"L. B. Zhang, R. R. Pang, Q. H. Qiao, Z. H. Wang, X. Y. Xia, C. J. Wang and X. L. Xu",2020,Successful recovery of COVID-19-associated recurrent diarrhea and gastrointestinal hemorrhage using convalescent plasma,Mil Med Res,https://www.ncbi.nlm.nih.gov/pubmed/32962760,10.1186/s40779-020-00273-5,IN,23/09/2020,case report study,,,,AB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,1,,,,,,,,,,
"J. L. Moore, P. V. Ganapathiraju, C. P. Kurtz and B. Wainscoat",2020,A 63-Year-Old Woman with a History of Non-Hodgkin Lymphoma with Persistent SARS-CoV-2 Infection Who Was Seronegative and Treated with Convalescent Plasma,Am J Case Rep,https://www.ncbi.nlm.nih.gov/pubmed/33009361,10.12659/AJCR.927812,in,24/09/2020,case report study,,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,,
"R. Shankar, N. Radhakrishnan, S. Dua, S. Arora, M. Rana, D. K. Sahu, S. Rai and D. K. Gupta",2021,Convalescent plasma to aid in recovery of COVID-19 pneumonia in a child with acute lymphoblastic leukemia,Transfus Apher Sci,https://www.ncbi.nlm.nih.gov/pubmed/32994125,10.1016/j.transci.2020.102956,IN,24/09/2020,case report study,,,,NO,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,1,,,1,,,,,1,,,,,,,,,,
"G. Vlachogianni, H. Hassapopoulou-Matamis, C. Politis, E. Fylaki and A. Mentis",2020,A case of COVID-19 Convalescent Plasma Donation in Greece: Directed donation for compassionate use in the donor's critically ill father,Transfus Clin Biol,,10.1016/j.tracli.2020.09.001,IN,25/09/2020,case report study,,,,AB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"F. Rahman, S. T. H. Liu, S. Taimur, S. Jacobs, T. Sullivan, D. Dunn, E. Baneman, R. Fuller, J. A. Aberg, N. Bouvier and M. M. Rana",2020,Treatment with convalescent plasma in solid organ transplant recipients with COVID-19: Experience at large transplant center in New York City,Clin Transplant,https://www.ncbi.nlm.nih.gov/pubmed/32918761,10.1111/ctr.14089,IN,28/09/2020,case series reports,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,,
"L. L. Zhang, Y. Liu, Y. G. Guo, J. Chang, B. Gao, Z. Z. Li, W. Geng, P. Hu, B. Song, X. Zhang and C. C. Wan",2021,Convalescent Plasma Rescued a Severe COVID-19 Patient with Chronic Myeloid Leukemia Blast Crisis and Myelofibrosis,Turk J Haematol,https://www.ncbi.nlm.nih.gov/pubmed/32988811,10.4274/tjh.galenos.2020.2020.0400,IN,29/09/2020,case report study,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,,
"S. E. González, L. Regairaz, N. S. Ferrando, V. V. González Martínez, M. R. Salazar and E. Estenssoro",2020,"[Convalescent plasma therapy in COVID-19 patients, in the Province of Buenos Aires]",Medicina (B Aires),,,IN,01/10/2020,non rct,,,,AB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"S. P. Schwartz, P. Thompson, M. Smith, D. M. Lercher, C. A. Rimland, L. Bartelt, Y. A. Park, S. Weiss, A. J. Markmann, R. Raut, L. Premkumar, J. Kuruc and Z. Willis",2020,Convalescent Plasma Therapy in Four Critically Ill Pediatric Patients With Coronavirus Disease 2019: A Case Series,Critical care explorations,,10.1097/cce.0000000000000237,IN,01/10/2020,case series reports,,,,NO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,1,,,,,,,,,,
"A. S. Omrani, A. Zaqout, A. Baiou, J. Daghfal, N. Elkum, R. A. Alattar, D. Bakdach, etal",2021,Convalescent plasma for the treatment of patients with severe coronavirus disease 2019: A preliminary report,J Med Virol,https://www.ncbi.nlm.nih.gov/pubmed/32965715,10.1002/jmv.26537,IN,05/10/2020,non rct,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,1,,1,,,,1,,,1,1,,
"E. Salazar, P. A. Christensen, E. A. Graviss, D. T. Nguyen, B. Castillo, J. Chen, B. V. Lopez, T. N. Eagar, X. Yi, P. Zhao, J. Rogers, A. Shehabeldin, D. Joseph, F. Masud, C. Leveque, R. J. Olsen, D. W. Bernard, J. Gollihar and J. M. Musser",2020,Early transfusion of a large cohort of COVID-19 patients with high titer anti-SARS-CoV-2 spike protein IgG convalescent plasma confirms a signal of significantly decreased mortality,medRxiv,http://www.epistemonikos.org/documents/d3b03560066366184129b592bce9e40202ba588c,10.1101/2020.10.02.20206029,IN,05/10/2020,non rct,Same as study above,,,NO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,1,,
"P. Bandopadhyay, R. D’Rozario, A. Lahiri, J. Sarif, Y. Ray, S. R. Paul, R. Roy, R. Maiti, K. Chaudhuri, S. Bagchi, A. Maiti, M. M. Perwez, B. S. Sarkar, D. Roy, R. Chakraborty, J. S. Vasudevan, S. Sharma, D. Biswas, C. Maiti, B. Saha, P. Bhattacharya, R. Pandey, S. Chatterjee, S. Paul and D. Ganguly",2020,Nature and dimensions of the cytokine storm and its attenuation by convalescent plasma in severe COVID-19,medRxiv,http://www.epistemonikos.org/documents/f2aa746af5fc9bffd4080c21683783a996bb76d9,10.1101/2020.09.21.20199109,IN,07/10/2020,rct,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1
"M. R. Salazar, S. E. González, L. Regairaz, N. S. Ferrando, V. V. González Martínez, P. M. Carrera Ramos, L. Muñoz, S. A. Pesci, J. M. Vidal, N. Kreplak and E. Estenssoro",2020,EFFECT OF CONVALESCENT PLASMA ON MORTALITY IN PATIENTS WITH COVID-19 PNEUMONIA,medRxiv,http://www.epistemonikos.org/documents/ae0186987aadacafbfcdede9301c1a407ff0da56,10.1101/2020.10.08.20202606,IN,09/10/2020,non rct,,,,NO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,1,,,,1,,,,1,,
"G. Katz-Greenberg, A. Yadav, M. Gupta, M. P. Martinez-Cantarin, R. Gulati, L. Ackerman, K. Belden and P. Singh",2020,Outcomes of COVID-19-positive kidney transplant recipients: A single-center experience,Clin Nephrol,,10.5414/cn110311,IN,09/10/2020,case report study,,,doi no longer works,BW,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"A. Choudhury, G. S. Reddy, S. Venishetty, V. Pamecha, S. M. Shasthry, A. Tomar, L. G. Mitra, V. S. T. Prasad, R. P. Mathur, D. Bhattacharya and S. K. Sarin",2020,COVID-19 in Liver Transplant Recipients - A Series with Successful Recovery,J Clin Transl Hepatol,https://www.ncbi.nlm.nih.gov/pubmed/33447532,10.14218/JCTH.2020.00061,IN,10/10/2020,case series reports,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,,
"W. R. Hartman, A. S. Hess and J. P. Connor",2020,Hospitalized COVID-19 patients treated with convalescent plasma in a mid-size city in the Midwest,Transl Med Commun,https://www.ncbi.nlm.nih.gov/pubmed/33072871,10.1186/s41231-020-00068-9,IN,12/10/2020,non rct,Same as above (which was a pre-print),,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,1,,
"S. B. Bradfute, I. Hurwitz, A. V. Yingling, C. Ye, Q. Cheng, T. P. Noonan, J. S. Raval, N. R. Sosa, G. J. Mertz, D. J. Perkins and M. S. Harkins",2020,Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibody Titers in Convalescent Plasma and Recipients in New Mexico: An Open Treatment Study in Patients With Coronavirus Disease 2019,J Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/32779705,10.1093/infdis/jiaa505,IN,13/10/2020,non rct,,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,1,,,,,,,,1,,,,,,,,,,
"T. Luetkens, R. Metcalf, V. Planelles, Y. Zheng, E. T. Larragoite, E. S. Spivak, A. M. Spivak, M. Steinbach, R. C. Blaylock, S. V. Avila, K. G. Hankey, T. B. Martins, P. R. Slev, H. D. Mannuel, M. Sajadi, A. P. Rapoport and D. Atanackovic",2020,Successful transfer of anti-SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19,Blood Adv,https://www.ncbi.nlm.nih.gov/pubmed/33031540,10.1182/bloodadvances.2020002595,in,13/10/2020,case report study,,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,,
"J. Pelayo, G. Pugliese, G. Salacup, E. Quintero, A. Khalifeh, D. Jaspan and B. Sharma",2020,Severe COVID-19 in Third Trimester Pregnancy: Multidisciplinary Approach,Case Rep Crit Care,https://www.ncbi.nlm.nih.gov/pubmed/33083063,10.1155/2020/8889487,IN,16/10/2020,case report study,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,,,,,
"P. Pal, M. Ibrahim, A. Niu, K. J. Zwezdaryk, E. Tatje, W. R. t. Robinson, L. Ko, I. etal",2021,Safety and efficacy of COVID-19 convalescent plasma in severe pulmonary disease: A report of 17 patients,Transfus Med,https://www.ncbi.nlm.nih.gov/pubmed/33073895,10.1111/tme.12729,IN,19/10/2020,case series reports,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,,
"A. Gemici, H. Bilgen, C. Erdoğan, A. Kansu, O. Olmuşçelik, H. S. Beköz, R. Çakmak, A. Mert and G. Sevindik Ö",2020,A single center cohort of 40 severe COVID-19 patients who were treated with convalescent plasma,Turk J Med Sci,,10.3906/sag-2009-77,IN,20/10/2020,non rct,,,,AB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"A. Agarwal, A. Mukherjee, G. Kumar, P. Chatterjee, T. Bhatnagar and P. Malhotra",2020,Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial),Bmj-British Medical Journal,<Go to ISI>://WOS:000581008000002,10.1136/bmj.m3939,IN,22/10/2020,rct,,,phase II,AB,,,,,,,,,,,,,,,,,,,,,,,,,1,,1,,,1,,,,1,,1,,1,,1,,1,,,1,,1,,1,1
"M. Donzelli, M. Ippolito, G. Catalisano, B. Renda, F. Tarantino, O. Diquattro and A. Cortegiani",2020,Prone positioning and convalescent plasma therapy in a critically ill pregnant woman with COVID-19,Clin Case Rep,,10.1002/ccr3.3426,IN,26/10/2020,case report study,,,,NO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"J. Malsy, L. Veletzky, J. Heide, A. Hennigs, I. Gil-Ibanez, A. Stein, M. Lutgehetmann, U. Rosien, D. Jasper, S. Peine, J. Hiller, F. Haag, S. Schmiedel, S. Huber, S. Jordan, M. M. Addo and J. Schulze Zur Wiesch",2020,Sustained response after remdesivir and convalescent plasma therapy in a B-cell depleted patient with protracted COVID-19,Clin Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/33103195,10.1093/cid/ciaa1637,IN,26/10/2020,case report study,,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,,
"D. Ragab, H. Salah-Eldin, M. Afify, W. Soliman and M. H. Badr",2021,"A case of COVID-19, with cytokine storm, treated by consecutive use of therapeutic plasma exchange followed by convalescent plasma transfusion: A case report",J Med Virol,,10.1002/jmv.26630,IN,27/10/2020,case report study,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"M. Bajpai, S. Kumar, A. Maheshwari, K. Chhabra, P. kale, A. Gupta, A. Narayanan, E. Gupta, N. Trehanpati, C. Bihari, R. Agarwal, K. Gupta, U. k. Gupta, A. Bhardwaj, G. Kumar, M. Islam, R. Singh, P. Yadav, R. Maiwall and S. K. Sarin",2020,Efficacy of Convalescent Plasma Therapy compared to Fresh Frozen Plasma in Severely ill COVID-19 Patients: A Pilot Randomized Controlled Trial,medRxiv,http://www.epistemonikos.org/documents/41f703fcee200191d3fc36bf9a5109feed090259,10.1101/2020.10.25.20219337,IN,27/10/2020,rct,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,1,,1,,,1,,1,1
"M. L. L. Madariaga, J. J. Guthmiller, S. Schrantz, M. O. Jansen, C. etal",2021,Clinical predictors of donor antibody titre and correlation with recipient antibody response in a COVID-19 convalescent plasma clinical trial,J Intern Med,https://www.ncbi.nlm.nih.gov/pubmed/33034095,10.1111/joim.13185,in,03/11/2020,non rct,,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,,,,,,,
O. Hamdy Salman and H. S. Ail Mohamed,2020,Efficacy and safety of transfusing plasma from COVID-19 survivors to COVID-19 victims with severe illness. A double-blinded controlled preliminary study,Egyptian Journal of Anaesthesia,http://www.epistemonikos.org/documents/565fa33a9b03d57a9d866718fd4b86d7e658f9fb,10.1080/11101849.2020.1842087,IN,03/11/2020,non rct,,,,AB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1
"V. Jaiswal, P. Nasa, M. Raouf, M. Gupta, H. Dewedar, H. Mohammad, Z. Al Rais, M. Ali Baqer, A. Alsabbah, Y. Ibrahim, M. Salem, D. Shammass and M. Marashi",2021,Therapeutic plasma exchange followed by convalescent plasma transfusion in critical COVID-19-An exploratory study,Int J Infect Dis,,10.1016/j.ijid.2020.10.085,IN,03/11/2020,case series reports,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"V. A. Avanzato, M. J. Matson, S. N. Seifert, R. Pryce, B. N. Williamson, S. L. Anzick, K. Barbian, S. D. Judson, E. R. Fischer, C. Martens, T. A. Bowden, E. de Wit, F. X. Riedo and V. J. Munster",2020,Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer,Cell,,10.1016/j.cell.2020.10.049,IN,04/11/2020,case report study,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"M. AlQahtani, A. Abdulrahman, A. Almadani, S. Y. Alali, A. M. Al Zamrooni, A. H. Hejab, R. M. Conroy, P. Wasif, S. L. Atkin, S. Otoom and M. Abduljalil",2020,Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease,medRxiv,http://www.epistemonikos.org/documents/4767c6f1ab5761bdaeeaa9950fd109c52a9f5fa8,10.1101/2020.11.02.20224303,IN,04/11/2020,rct,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,1,,1,,,,,1,1
"E. Salazar, P. A. Christensen, E. A. Graviss, D. T. Nguyen, B. Castillo, J. Chen, B. V. Lopez, T. N. Eagar, X. Yi, P. Zhao, J. Rogers, A. Shehabeldin, D. Joseph, F. Masud, C. Leveque, R. J. Olsen, D. W. Bernard, J. Gollihar and J. M. Musser",2021,Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG,Am J Pathol,https://www.ncbi.nlm.nih.gov/pubmed/33157066,10.1016/j.ajpath.2020.10.008,IN,04/11/2020,non rct,,,,NO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,1,,1,,,1,,,,,,,
"B. Einollahi, L. Cegolon, H. Abolghasemi, S. Imanizadeh, A. Bahramifar, S. Zhao, R. Jafari and M. Javanbakht",2020,"A patient affected by critical COVID-19 pneumonia, successfully treated with convalescent plasma",Transfus Apher Sci,,10.1016/j.transci.2020.102995,IN,05/11/2020,case report study,,,one case,AB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"F. Ji, W. Liu, D. A. Hao, J. Cheng, X. C. Tong, J. G. Hao, L. P. Wang, C. Y. Li, M. J. Dai and X. B. Yan",2021,Use of convalescent plasma therapy in eight individuals with mild COVID-19,New Microbes New Infect,,10.1016/j.nmni.2020.100814,IN,13/11/2020,case series reports,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"K. F. A. Van Damme, S. Tavernier, N. Van Roy, E. De Leeuw, J. Declercq, C. Bosteels, B. Maes, M. De Bruyne, D. Bogaert, V. Bosteels, L. Hoste, L. Naesens, P. Maes, A. Grifoni, D. Weiskopf, A. Sette, P. Depuydt, E. Van Braeckel, F. Haerynck and B. N. Lambrecht",2020,"Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19",Front Immunol,,10.3389/fimmu.2020.596761,IN,20/11/2020,case report study,,,,AB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"J. London, D. Boutboul, K. Lacombe, F. Pirenne, B. Heym, V. Zeller, A. Baudet, A. Ouedrani and A. Bérezné",2021,Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy,J Clin Immunol,,10.1007/s10875-020-00904-5,in,20/11/2020,case report study,,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"S. Huang, C. Shen, C. Xia, X. Huang, Y. Fu and L. Tian",2020,"A Retrospective Study on the Effects of Convalescent Plasma Therapy in 24 Patients Diagnosed with COVID-19 Pneumonia in February and March 2020 at 2 Centers in Wuhan, China",Med Sci Monit,,10.12659/msm.928755,IN,21/11/2020,case series reports,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"R. Libster, G. P. Marc, D. etal",2020,Prevention of severe COVID-19 in the elderly by early high-titer plasma,medRxiv,http://www.epistemonikos.org/documents/f34c371a6b68790cfd2f1394cd5c4b40b36a7f8a,10.1101/2020.11.20.20234013,IN,21/11/2020,rct,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,1
"A. Gharbharan, C. Jordans, C. GeurtsvanKessel, J. d. Hollander, F. Karim, etal",2020,Effects of Potent Neutralizing Antibodies from Convalescent Plasma in Patients Hospitalized for Severe SARS-CoV-2 Infection,ResearchSquare,http://www.epistemonikos.org/documents/ba1515e4bc06c1b5dd035c278393824cbb184063,10.21203/rs.3.rs-105265/v1,IN,23/11/2020,rct,,,preprint,AB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1
"J. G. Hovey, D. Tolbert and D. Howell",2020,Burton's Agammaglobulinemia and COVID-19,Cureus,,10.7759/cureus.11701,IN,25/11/2020,case report study,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"Y. Ray, S. R. Paul, P. Bandopadhyay, R. D’Rozario, J. Sarif, etal",2020,Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial,medRxiv,http://www.epistemonikos.org/documents/40b2b3a2b1dc8d25d37b0a66a94c224ffa71893e,10.1101/2020.11.25.20237883,IN,29/11/2020,rct,,,,NO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,1,1,1,,,1,,1,1
"M. Fung, A. Nambiar, S. Pandey, J. M. Aldrich, J. Teraoka, C. Freise, J. Roberts, S. Chandran, S. R. Hays, E. Bainbridge, C. DeVoe, A. Roque Gardner, D. Yokoe, T. J. Henrich, J. M. Babik and P. Chin-Hong",2021,Treatment of immunocompromised COVID-19 patients with convalescent plasma,Transpl Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/32989856,10.1111/tid.13477,IN,29/11/2020,case series reports,,,4 cases,AB,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,,,1,,,,,,,,,,
"I. Milošević, J. Jovanović and O. Stevanovic",2020,Atypical course of COVID-19 in patient with Bruton agammaglobulinemia,J Infect Dev Ctries,,10.3855/jidc.13840,in,30/11/2020,case report study,not cpt,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"I. Jamir, P. Lohia, R. K. Pande, R. Setia, A. K. Singhal and A. Chaudhary",2020,Convalescent plasma therapy and remdesivir duo successfully salvaged an early liver transplant recipient with severe COVID-19 pneumonia,Ann Hepatobiliary Pancreat Surg,,10.14701/ahbps.2020.24.4.526,IN,30/11/2020,case report study,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"C. Perotti, F. Baldanti, R. Bruno, C. Del Fante, E. Seminari, S. Casari, E. Percivalle, C. Glingani, V. Musella, M. Belliato, M. Garuti, F. Meloni, M. Frigato, A. Di Sabatino, C. Klersy, G. De Donno, M. Franchini and C.-P. T. Collaborative",2020,"Mortality reduction in 46 patients with severe COVID-19 treated with hyperimmune plasma A proof-of-concept, single-arm, multicenter trial",Haematologica,<Go to ISI>://WOS:000596541600020,10.3324/haematol.2020.261784,IN,01/12/2020,case series reports,,,,MR,,,,,,,,,,,,,,,,,,,1,,,,,1,1,,,,,1,,1,1,,,,,,,1,,,,,,,1,1,,
"R. Gazitúa, J. L. Briones, C. Selman, F. Villarroel-Espíndola, A. Aguirre, R. González-Steigmaier, K. Cereceda, M. Mahave, B. Rubio, P. Ferrer-Rosende, J. Sapunar, H. Marsiglia, R. Morales, F. Yarad, M. E. Balcells, L. Rojas, B. Nervi, J. K. Nien, J. Garate, C. Prieto, S. Palma, C. Escobar, J. Bascuñan, R. Muñoz, M. Pinto, D. Cardemil, M. Navarrete, S. Reyes, V. Espinosa, N. Yáñez and C. Caglevic",2020,Convalescent Plasma in COVID-19. Mortality-Safety First Results of the Prospective Multicenter FALP 001-2020 Trial,medRxiv,https://www.medrxiv.org/content/medrxiv/early/2020/12/02/2020.11.30.20218560.full.pdf,10.1101/2020.11.30.20218560,IN,02/12/2020,non rct,,,,AB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"H. A. Yoon, R. Bartash, I. Gendlina, J. Rivera, A. Nakouzi, etal",2020,"Treatment of Severe COVID-19 with Convalescent Plasma in the Bronx, NYC",medRxiv : the preprint server for health sciences,,10.1101/2020.12.02.20242909,IN,04/12/2020,non rct,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,
"A. P. H. Yokoyama, S. Wendel, C. Bonet-Bub, R. M. Fachini, etal",2020,Impact of Convalescent Plasma Transfusion (CCP) In Patients With Previous Circulating Neutralizing Antibodies (nAb) to COVID-19,medRxiv,https://www.medrxiv.org/content/medrxiv/early/2020/12/11/2020.12.08.20246173.full.pdf,10.1101/2020.12.08.20246173,IN,11/12/2020,case series reports,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"A. Betrains, L. Godinas, A. J. F. Woei, W. etal",2021,Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies,Br J Haematol,,10.1111/bjh.17266,IN,13/12/2020,case report study,,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"X. Hu, C. Hu, D. Jiang, Q. Zuo, Y. Li, Y. Wang and X. Chen",2020,"Effectiveness of Convalescent Plasma Therapy for COVID-19 Patients in Hunan, China",Dose Response,,10.1177/1559325820979921,IN,15/12/2020,case report study,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"W. J. Jiang, W. W. Li, L. Xiong, Q. Y. Wu, J. Wu, B. S. He, J. W. Shen, R. R. Pang, T. Luo, Y. J. Guo, Y. Yang, Y. Han, W. Dai, P. R. Zhu and X. Y. Xia",2020,Clinical efficacy of convalescent plasma therapy on treating COVID-19 patients: Evidence from matched study and a meta-analysis,Clinical and Translational Medicine,<Go to ISI>://WOS:000603671400005,10.1002/ctm2.259,IN,21/12/2020,non rct,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,1,,,,,,
"A. Moniuszko-Malinowska, P. Czupryna, D. Zarębska-Michaluk, K. Tomasiewicz, S. etal",2020,Convalescent Plasma Transfusion for the Treatment of COVID-19-Experience from Poland: A Multicenter Study,J Clin Med,,10.3390/jcm10010028,in,24/12/2020,non rct,,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"N. AlShehry, S. Z. A. Zaidi, A. AlAskar, A. Al Odayani, J. M. Alotaibi, A. AlSagheir, A. Al-Eyadhy, S. Balelah, A. Salam, A. R. Z. Zaidi, D. Alawami, M. S. Alshahrani, N. AlMozain, Y. M. Abulhamayel, R. Al Qunfoidi, M. Alfaraj, N. Qushmaq, R. Alansari, A. Dayel, G. Elgohary, A. Al Bahrani, A. A. Nabhan Abdelhameed, H. A. AlZahrani, H. Alturkistani, N. AlShehry, M. A. Albalawi, I. Elalfy, H. Alhumaidan and H. Al-Hashmi",2021,Safety and Efficacy of Convalescent Plasma for Severe COVID-19: Interim Report of a Multicenter Phase II Study from Saudi Arabia,Saudi J Med Med Sci,,10.4103/sjmms.sjmms_731_20,IN,26/12/2020,non rct,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"S. A. Mehta, M. M. Rana, J. D. Motter, C. B. Small, M. R. Pereira, V. etal",2021,Incidence and Outcomes of COVID-19 in Kidney and Liver Transplant Recipients With HIV: Report From the National HOPE in Action Consortium,Transplantation,,10.1097/tp.0000000000003527,in,01/01/2021,case report study,,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"M. Klapholz, S. R. Pentakota, J. P. Zertuche, M. McKenna, W. Roque, M. Forsberg, J. Packer, D. S. Lal and L. Dever",2021,Matched Cohort Study of Convalescent COVID-19 Plasma Treatment in Severely or Life Threateningly Ill COVID-19 Patients,Open Forum Infect Dis,,10.1093/ofid/ofab001,IN,04/01/2021,non rct,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"M. Lubnow, B. Schmidt, M. Fleck, B. Salzberger, T. Müller, G. etal",2021,Secondary hemophagocytic lymphohistiocytosis and severe liver injury induced by hepatic SARS-CoV-2 infection unmasking Wilson's disease: Balancing immunosuppression,Int J Infect Dis,,10.1016/j.ijid.2020.12.047,in,04/01/2021,case report study,,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"T. A. Szwebel, D. Veyer, N. Robillard, D. Eshagh, E. Canoui, T. Bruneau, A. Contejean, C. Azoulay, T. Serrano, T. Hueso, L. Izquierdo, F. Rozenberg, B. Terrier, M. Vignon, P. Laurent-Puig, V. Taly, L. Bélec, S. Kernéis, K. Lacombe and H. Péré",2021,Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma Patient,Stem Cell Rev Rep,,10.1007/s12015-020-10107-5,IN,05/01/2021,case report study,,,,NO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"D. L. Fisher, A. Pavel and S. Malnick",2021,Rapid recovery of taste and smell in a patient with SARS-CoV-2 following convalescent plasma therapy,Qjm,,10.1093/qjmed/hcaa341,IN,08/01/2021,case report study,,,1 case,AB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
H. W. R. H. A. S. C. Joseph,2021,Use of COVID-19 Convalescent Plasma as Prophylaxis in a Patient with New Onset All,"Case Report, Clin Oncol Case Rep",,,IN,10/01/2021,case report study,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
R. T. Investigators,2021,RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19,"Press release - Statement from the RECOVERY trial chief investigators, 15 January 2021",http://www.epistemonikos.org/documents/cd497a5bfa21a3d35017eb146b684d7db7956927,,IN,15/01/2021,rct,Press release of Hornby,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,
"S. Ferrari, C. Caprioli, A. Weber, A. Rambaldi and F. Lussana",2021,Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies,Leuk Lymphoma,,10.1080/10428194.2021.1872070,IN,18/01/2021,case series reports,,,7 cases,AB,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"E. Diago-Sempere, J. L. Bueno, A. Sancho-Lopez, E. M. Rubio, F. Torres, R. M. de Molina, A. Fernandez-Cruz, I. S. de Diego, A. Velasco-Iglesias, C. Payares-Herrera, I. C. Flecha, C. Avendano-Sola, R. D. Palomino, A. Ramos-Martinez and B. Ruiz-Antoran",2021,"Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial",Trials,https://www.ncbi.nlm.nih.gov/pubmed/33472681,10.1186/s13063-020-05011-9,IN,20/01/2021,rct,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1
"H. A. Yoon, R. Bartash, I. Gendlina, J. Rivera, A. Nakouzi, R. H. Bortz, etal",2021,"Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC",JCI Insight,https://www.ncbi.nlm.nih.gov/pubmed/33476300,10.1172/jci.insight.142270,IN,22/01/2021,non rct,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,1,,,
"V. A. Simonovich, L. D. Burgos Pratx, P. Scibona, M. V. Beruto, M. G. V etal",2021,A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia,N Engl J Med,https://www.ncbi.nlm.nih.gov/pubmed/33232588,10.1056/NEJMoa2031304,IN,18/02/2021,rct,,,,NO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,1,,1,,1,,1,1,,1,,1,1
"R. Libster, G. Perez Marc, D. Wappner, S.ietal",2021,Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults,N Engl J Med,https://www.ncbi.nlm.nih.gov/pubmed/33406353,10.1056/NEJMoa2033700,IN,18/02/2021,rct,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,1,,1,1,1,,,,,1,1
"S. Budhiraja, A. Dewan, R. Aggarwal, O. Singh, D. Juneja, S. Pathak, Y. P. Singh, A. Gupta, R. Rai, A. Indrayan, V. Jha and R. Naithani",2021,Effectiveness of convalescent plasma in Indian patients with COVID-19,Blood Cells Mol Dis,,10.1016/j.bcmd.2021.102548,IN,18/02/2021,non rct,,,,JTC,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"P. W. Horby, L. Estcourt, L. Peto, J. R. Emberson, N. Staplin, E. Spata, G. Pessoa-Amorim, M. Campbell, A. Roddick, N. E. Brunskill, T. George, D. Zehnder, S. Tiberi, N. N. Aung, A. Uriel, J. Widdrington, G. Koshy, T. Brown, S. Scott, J. K. Baillie, M. H. Buch, L. C. Chappell, J. N. Day, S. N. Faust, T. Jaki, K. Jeffery, E. Juszczak, W. S. Lim, A. Montgomery, A. Mumford, K. Rowan, G. Thwaites, M. Mafham, D. Roberts, R. Haynes and M. J. Landray",2021,"Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial",medRxiv,http://www.epistemonikos.org/documents/bd9b9a121fa09f8cedb52a48c4e5080b3f1b4fc6,10.1101/2021.03.09.21252736,IN,10/03/2021,rct,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,1
"M. R. O’Donnell, B. Grinsztejn, M. J. Cummings, J. Justman, M. R. Lamb, etal",2021,"A randomized, double-blind, controlled trial of convalescent plasma in adults with severe COVID-19",medRxiv,http://www.epistemonikos.org/documents/7d0ffefb14ca100bd77eb742f59c27fa693fa217,10.1101/2021.03.12.21253373,In,13/03/2021,rct,,,,MR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1
"M. L. Donato, S. Park, M. Baker, R. Korngold, A. Morawski, etal",2021,Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma,JCI Insight,https://www.ncbi.nlm.nih.gov/pubmed/33571168,10.1172/jci.insight.143196,IN,22/03/2021,non rct,,,,NO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,
"M. N. Klein, E. W. Wang, P. Zimand, H. Beauchamp, C. Donis, M. D. Ward, A. Martinez-Hernandez, A. Tabatabai, J. W. Baddley, E. M. Bloch, K. E. Mullins and M. J. Fontaine",2021,Kinetics of SARS-CoV-2 antibody responses pre-COVID-19 and post-COVID-19 convalescent plasma transfusion in patients with severe respiratory failure: an observational case-control study,J Clin Pathol,,10.1136/jclinpath-2020-207356,IN,23/04/2021,non rct,,,,BW,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,,,,
"M. AlQahtani, A. Abdulrahman, A. Almadani, S. Y. Alali, A. M. Al Zamrooni, A. H. Hejab, R. M. Conroy, P. Wasif, S. Otoom, S. L. Atkin and M. Abduljalil",2021,Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease,Sci Rep,https://www.ncbi.nlm.nih.gov/pubmed/33976287,10.1038/s41598-021-89444-5,IN,11/05/2021,rct,Same as above (which was a pre-print),,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,,1,,,
"R. Rogers, F. Shehadeh, E. K. Mylona, J. Rich, M. Neill, F. Touzard-Romo, S. Geffert, J. Larkin, J. A. Bailey, S. Lu, J. Sweeney and E. Mylonakis",2020,Convalescent plasma for patients with severe COVID-19: a matched cohort study,Clin Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/33038227,10.1093/cid/ciaa1548,IN,01/07/2021,non rct,,,,NO,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,,,,,1,,1,,,,,,,1,1,,
"S. Alsharidah, M. Ayed, R. M. Ameen, F. Alhuraish, N. A. Rouheldeen, F. R. Alshammari, A. Embaireeg, M. Almelahi, M. Adel, M. E. Dawoud, M. A. Aljasmi, N. Alshammari, A. Alsaeedi, W. Al-Adsani, H. Arian, H. Awad, H. A. Alenezi, A. Alzafiri, E. F. Gouda, M. Almehanna, S. Alqahtani, A. Alshammari and M. Z. Askar",2021,COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study,Int J Infect Dis,https://www.ncbi.nlm.nih.gov/pubmed/33285283,10.1016/j.ijid.2020.11.198,IN,04/12/2021,non rct,,,,BA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,,1,,,,1,,,,,,
